Literature DB >> 34208847

The Many Applications of Engineered Bacteriophages-An Overview.

Bryan Gibb1, Paul Hyman2, Christine L Schneider3.   

Abstract

Since their independent discovery by Frederick Twort in 1915 and Felix d'Herelle in 1917, bacteriophages have captured the attention of scientists for more than a century. They are the most abundant organisms on the planet, often outnumbering their bacterial hosts by tenfold in a given environment, and they constitute a vast reservoir of unexplored genetic information. The increased prevalence of antibiotic resistant pathogens has renewed interest in the use of naturally obtained phages to combat bacterial infections, aka phage therapy. The development of tools to modify phages, genetically or chemically, combined with their structural flexibility, cargo capacity, ease of propagation, and overall safety in humans has opened the door to a myriad of applications. This review article will introduce readers to many of the varied and ingenious ways in which researchers are modifying phages to move them well beyond their innate ability to target and kill bacteria.

Entities:  

Keywords:  bacteriophage; engineered phage; imaging agent; pathogen detection; phage therapy

Year:  2021        PMID: 34208847     DOI: 10.3390/ph14070634

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  124 in total

1.  A hybrid vector for ligand-directed tumor targeting and molecular imaging.

Authors:  Amin Hajitou; Martin Trepel; Caroline E Lilley; Suren Soghomonyan; Mian M Alauddin; Frank C Marini; Bradley H Restel; Michael G Ozawa; Catherine A Moya; Roberto Rangel; Yan Sun; Karim Zaoui; Manfred Schmidt; Christof von Kalle; Matthew D Weitzman; Juri G Gelovani; Renata Pasqualini; Wadih Arap
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.

Authors:  Pan Tao; Xiaorong Wu; Wei-Chun Tang; Jingen Zhu; Venigalla Rao
Journal:  ACS Synth Biol       Date:  2017-07-13       Impact factor: 5.110

3.  A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.

Authors:  Roberto Díez-Martínez; Héctor D De Paz; Esther García-Fernández; Noemí Bustamante; Chad W Euler; Vincent A Fischetti; Margarita Menendez; Pedro García
Journal:  J Antimicrob Chemother       Date:  2015-03-01       Impact factor: 5.790

4.  Preclinical evaluation of the breast cancer cell-binding peptide, p160.

Authors:  Vasileios Askoxylakis; Sabine Zitzmann; Walter Mier; Keith Graham; Susanne Krämer; Frederic von Wegner; Rainer H A Fink; Manfred Schwab; Michael Eisenhut; Uwe Haberkorn
Journal:  Clin Cancer Res       Date:  2005-09-15       Impact factor: 12.531

5.  Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms.

Authors:  Justine Monnerat Tinoco; Bettina Buttaro; Hongming Zhang; Nadia Liss; Luciana Sassone; Roy Stevens
Journal:  Arch Oral Biol       Date:  2016-07-06       Impact factor: 2.633

6.  Biotin binders selected from a random peptide library expressed on phage.

Authors:  I Saggio; R Laufer
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

7.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.

Authors:  Robert J Citorik; Mark Mimee; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2014-09-21       Impact factor: 54.908

8.  Strategies for Editing Virulent Staphylococcal Phages Using CRISPR-Cas10.

Authors:  S M Nayeemul Bari; Forrest C Walker; Katie Cater; Barbaros Aslan; Asma Hatoum-Aslan
Journal:  ACS Synth Biol       Date:  2017-09-21       Impact factor: 5.110

9.  Phage as versatile nanoink for printing 3-D cell-laden scaffolds.

Authors:  Doe-Young Lee; Hyeongjin Lee; YongBok Kim; So Young Yoo; Woo-Jae Chung; GeunHyung Kim
Journal:  Acta Biomater       Date:  2015-10-09       Impact factor: 8.947

10.  Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.

Authors:  Mathias Schmelcher; Vincent S Tchang; Martin J Loessner
Journal:  Microb Biotechnol       Date:  2011-04-27       Impact factor: 5.813

View more
  5 in total

Review 1.  [Cancer Neuroscience].

Authors:  Varun Venkataramani; Frank Winkler
Journal:  Nervenarzt       Date:  2022-09-21       Impact factor: 1.297

Review 2.  Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens.

Authors:  Jennifer Venhorst; Jos M B M van der Vossen; Valeria Agamennone
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

Review 3.  Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review.

Authors:  Siyu Liu; Hongyun Lu; Shengliang Zhang; Ying Shi; Qihe Chen
Journal:  Pharmaceutics       Date:  2022-02-16       Impact factor: 6.321

4.  Novel Bacteriophages Show Activity against Selected Australian Clinical Strains of Pseudomonas aeruginosa.

Authors:  Samuel Namonyo; Gilda Carvalho; Jianhua Guo; Karen D Weynberg
Journal:  Microorganisms       Date:  2022-01-19

5.  Treating bacterial infections with bacteriophages in the 21st century.

Authors:  Christoffel J Opperman; Justyna M Wojno; Adrian J Brink
Journal:  S Afr J Infect Dis       Date:  2022-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.